medigraphic.com
ISSN 0016-3813 (Print)

2013, Number 6

<< Back Next >>

Gac Med Mex 2013; 149 (6)

Vision-threatening retinopathy in diabetics not referred to an ophthalmologist

Ávila AY, Lima GV

Language: Spanish
References: 20
Page: 624-629
PDF size: 186.25 Kb.


ABSTRACT

Background: Vision-threatening forms of diabetic retinopathy (macular edema and proliferative retinopathy) can be efficiently treated with laser. Any delay in access to ophthalmic care may limit the opportunity of treatment. Diabetics that are not referred to an ophthalmologist are a vulnerable population, which could lose vision as a result of delayed attention. Material and methods: Observational, descriptive, prospective, cross-sectional study in diabetics attending a hospital for non-ophthalmological causes, without prior evaluation of the ocular fundus. The proportion of eyes with visionthreatening diabetic retinopathy, and that of eyes in which visual loss could be prevented were identified. Results: 100 patients, mean age 55.5 years, 53 females; 48 had diabetic retinopathy, six had proliferative retinopathy (6%; 95% CI: 1.3-10.7), and 23 had macular edema (23%; 95% CI: 14.8-31.2); the proportion of diabetic macular edema was higher than the one reported in the same population 15 years before (odds ratio 4.01; 95% CI: 1.98-8.15). Fifty-six percent of the patients with visionthreatening retinopathy did not have visual deficiency. Conclusion: Detection and referral of diabetic patients with risk of visual loss must be made easier, regardless of their visual symptoms, in order to achieve treatment efficacy by timely care.


REFERENCES

  1. Cheung N, Mitchell P, Wong TY. Diabetic Retinopathy. Lancet. 2010; 376:124-36.

  2. Yau JW, Rogers SL, Kawasaki R. Global prevalence and mayor risk factor of diabetic retinopathy. Diabetes Care. 2012;35:556-64.

  3. Sociedad Mexicana de Oftalmología, Asociación Mexicana de Retina, Asociación Panamericana de Oftalmología. Resultados del Día Panamericano de Detección de Retinopatía Diabética (3 de julio 1999, día “D”). Rev Mex Oftalmol. 2005;79:88-92.

  4. American Academy of Ophthalmology Retina Panel. Preferred Practice Pattern Guidelines. Diabetic Retinopaty. San Francisco, DA: American Academy of Ophthalmology; 2008 (4th printing 2012). [Internet] Disponible en: www. Aao. Org/ppp.

  5. Varma R, Choudhury R, Klein R, Chung J. Four year incidence and Progression of diabetic retinopathy and macular edema. The Los Angeles Latino eye study. Am J Ophthalmol. 2010;149:752-61.

  6. Lima-Gómez V, Rojas-Dosal JA, Aguilera-Cartas MA. Presentación de la retinopatía diabética en un hospital de población abierta. Cir Ciruj. 1999;67:168-72.

  7. Lima-Gómez V, Olivares-Morales O, Razo-Blanco HDM, Hernández- Rojas ML. Deficiencia visual al momento del diagnóstico del EMCS en diabéticos mexicanos. Salud Publica Mex. 2008;50(5):354-5.

  8. Lima-Gómez V, Mijangos-Medina LF, Hernández-Orgaz JJ, Bermúdez- Zapata DA. Eficacia de la cirugía vitreorretiniana para mejorar la capacidad visual en diabéticos con retinopatía. Cir Ciruj. 2012;80:490-5.

  9. Prado-Serrano A, Guido JM, Camas BJ. Prevalencia de la retinopatía diabética en población mexicana. Rev Mex Oftalmol. 2009;83:261-6.

  10. Varma R, Torres M, Peña F, Klein F. Prevalence of diabetic retinopathy in adult latinos. The Los Angeles Latino Eye Study. Ophthalmology. 2004;111:1298-306.

  11. Polack S, Yorston D, López-Ramos A, et al. Rapid Assessment of Avoidable Blindness and Diabetic Retinopathy in Chiapas, México. Ophthalmology. 2012;119:1033-40.

  12. Goncalves EP, Faria de Arantes EP, Figueiroa FN, Deus VR, Tobosa ET, Lima AA. Epidemiology and regional differences of diabetic retinopathy in Pernambuco Brazil Arq Bras Oftalmol. 2008;7:172-5.

  13. Villena JE, Yoshiyama CA, Sánchez JE, Hilario NL, Merin LM. Prevalence of diabetic retinopathy in Peruvian patients with type 2 diabetes: results of a hospital-based retinal telescreening program. Rev Panam Salud Publica. 2011;30:408-14.

  14. Perera ME, Ramos LC, Padilla GC, Hernández SJ, Ruiz MM, Hernández RH. Comportamiento clínico-epidemiológico de la retinopatía diabética en el municipio de Marianao de agosto a noviembre, 2007. Revista Cubana de Oftalmología. 2011;24:287-98.

  15. Sivaprasad S, Gupta B, Crosby-Nwaobi R, Evans J. Prevalence of Diabetic Retinopathy in Various Ethnic Groups: A Worldwide Perspective. Surv Ophthalmol. 2012;57:347-70.

  16. Romero-Aroca P, Fernández-Balart J, Baget-Bernaldiz M, et. al. Changes in the diabetic retinopathy epidemiology after 14 years in a population of type 1 and 2 diabetic mellitus patients after the new diabetes mellitus diagnosis criteria and more strict control of the patients. J Diabetes Complications. 2009;23(4):229-38.

  17. Hazin R, Barazi KM, Summerfield M. Challenges to establishing nationwide diabetic retinopathy screening programs. Curr Opin Ophthalmol. 2011;22:174-9.

  18. Einarsdottir AB, Stefánnson E. Prevention of diabetic retinopathy. Lancet. 2009;373:1316.

  19. Stéfansson E, Bek T, Porta M, Larsen N, Kari KJ, Agardh E. Screening and Prevention of diabetic blindness. Acta Ophthalmol Scand. 2000;78:374-85.

  20. George HB, Makamel DB, Kickinson JC, Cole DR. A screening approach to the surveillance of patients with diabetes for the presence of visiónthreatening retinopathy. Ophthalmology. 2000;107:19-24.




2020     |     www.medigraphic.com